The role of GRIK4 gene in treatment-resistant depression
- PMID: 26139080
- PMCID: PMC6863631
- DOI: 10.1017/S0016672315000142
The role of GRIK4 gene in treatment-resistant depression
Abstract
Several lines of evidence implicate abnormalities in glutamatergic neural transmission in major depressive disorder (MDD) and treatment response. A high percentage of MDD patients do not respond adequately to antidepressants and are classified as having treatment-resistant depression (TRD). In this study we investigated five GRIK4 variants, previously associated with antidepressants response, in an Italian cohort of 247 MDD no-TRD and 380 TRD patients. We found an association between rs11218030 G allele and TRD. Moreover, significant associations between rs11218030 and rs1954787 and the presence of psychotic symptoms were observed. In conclusion, our data support the involvement of GRIK4 in TRD and in the risk of developing psychotic symptoms during depressive episodes.
Figures
Similar articles
-
Influence of GRIK4 genetic variants on the electroconvulsive therapy response.Neurosci Lett. 2016 Jul 28;626:94-8. doi: 10.1016/j.neulet.2016.05.030. Epub 2016 May 17. Neurosci Lett. 2016. PMID: 27222927
-
The role of the potassium channel gene KCNK2 in major depressive disorder.Psychiatry Res. 2015 Feb 28;225(3):489-92. doi: 10.1016/j.psychres.2014.11.061. Epub 2014 Dec 9. Psychiatry Res. 2015. PMID: 25535009
-
Association of the GRIK4 rs1954787 polymorphism with clinical response in antidepressant-treated depressed patients: results from a prospective cohort and meta-analysis.Mol Psychiatry. 2025 Apr;30(4):1529-1538. doi: 10.1038/s41380-024-02765-5. Epub 2024 Oct 26. Mol Psychiatry. 2025. PMID: 39462036
-
The Wistar-Kyoto rat model of endogenous depression: A tool for exploring treatment resistance with an urgent need to focus on sex differences.Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109908. doi: 10.1016/j.pnpbp.2020.109908. Epub 2020 Mar 4. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 32145362 Review.
-
Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.Int J Environ Res Public Health. 2018 Apr 17;15(4):771. doi: 10.3390/ijerph15040771. Int J Environ Res Public Health. 2018. PMID: 29673146 Free PMC article. Review.
Cited by
-
Treatment-resistant depression: molecular mechanisms and management.Mol Biomed. 2024 Oct 17;5(1):43. doi: 10.1186/s43556-024-00205-y. Mol Biomed. 2024. PMID: 39414710 Free PMC article. Review.
-
The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives.Int J Neuropsychopharmacol. 2019 Feb 1;22(2):93-104. doi: 10.1093/ijnp/pyy024. Int J Neuropsychopharmacol. 2019. PMID: 29688548 Free PMC article. Review.
-
Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders.Neuropsychopharmacology. 2017 Mar;42(4):787-800. doi: 10.1038/npp.2016.149. Epub 2016 Aug 11. Neuropsychopharmacology. 2017. PMID: 27510426 Free PMC article. Review.
-
GRIK4 and GRM7 gene may be potential indicator of venlafaxine treatment reponses in Chinese of Han ethnicity.Medicine (Baltimore). 2019 May;98(19):e15456. doi: 10.1097/MD.0000000000015456. Medicine (Baltimore). 2019. PMID: 31083176 Free PMC article.
-
Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.CNS Drugs. 2016 Dec;30(12):1169-1189. doi: 10.1007/s40263-016-0385-9. CNS Drugs. 2016. PMID: 27752945 Review.
References
-
- Bentley S. M., Pagalilauan G. L. & Simpson S. (2014). Major depression. The Medical Clinics of North America 98, 981–1005. - PubMed
-
- Blackwood D. H., Pickard B. J., Thomson P. A., Evans K. L., Porteous D. J. & Muir W. J. (2007). Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1. Neurotoxicity Research 11, 73–83. - PubMed
-
- Boyer P., Skolnick P. & Fossom L. H. (1998). Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. Journal of Molecular Neuroscience 10, 219–233. - PubMed
-
- Carvalho A. F., Berk M., Hyphantis T. N. & McIntyre R. S. (2014). The integrative management of treatment-resistant depression: a comprehensive review and perspectives. Psychotherapy and Psychosomatics 83, 70–88. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources